Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04504136 · ClinicalTrials.gov registry record · NA

Regulation of Mucosal Healing in Inflammatory Bowel Disease

A NA study of Inflammatory Bowel Diseases, sponsored by Terrence A Barrett.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT04504136 is a NA study of Inflammatory Bowel Diseases that is actively recruiting participants, run by Terrence A Barrett. The registered enrollment target is 60 participants, below the 42,260-participant average among 48 other Inflammatory Bowel Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04504136, a NA study of Inflammatory Bowel Diseases, is actively recruiting participants, sponsored by Terrence A Barrett.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The objective of the current study is to compare non-healing colonic ulcers in patients with inflammatory bowel disease (IBD) with iatrogenic colonic ulcers (biopsy sites) in healthy control patients and patients with rheumatoid or psoriatic arthritis. Patients will be biopsied at baseline and again at a follow-up visit in a "biopsy of the biopsy" approach. These biopsies will be used to reveal patterns about gene expression and mitochondrial function during ulcer healing.

Interventions

  • PROCEDURE Serial Biopsy

Study Locations (1)

Kentucky

  • University of Kentucky - Lexington

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2021-04-30
Est. Completion 2026-06-01
Phase NA

Sponsor

Terrence A Barrett

1 total trials

What the Registry Record Tells You About NCT04504136

The ClinicalTrials.gov registry entry for NCT04504136 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 42,260-participant average among 48 other Inflammatory Bowel Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Terrence A Barrett, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Inflammatory Bowel Diseases appearing as the primary indexed condition, and to 1 intervention - of which Serial Biopsy is the first listed.

NCT04504136 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT04504136 about?

NCT04504136 is a clinical study titled "Regulation of Mucosal Healing in Inflammatory Bowel Disease". The objective of the current study is to compare non-healing colonic ulcers in patients with inflammatory bowel disease (IBD) with iatrogenic colonic ulcers (biopsy sites) in healthy control patients and patients with rheumatoid or psoriatic arthritis. Patients will be biopsied at baseline and again...

What is the current status of trial NCT04504136?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2021-04-30. Estimated completion is 2026-06-01.

What conditions does trial NCT04504136 study?

This clinical trial studies the following conditions: Inflammatory Bowel Diseases.

What interventions are being tested in trial NCT04504136?

The interventions under investigation include: Serial Biopsy (PROCEDURE).

Who is sponsoring clinical trial NCT04504136?

This trial is sponsored by Terrence A Barrett, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04504136 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammatory Bowel Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.